Suppr超能文献

用于犬安乐死之前口服诱导镇静的五种给药方案的比较。

Comparison of five regimens for oral administration of medication to induce sedation in dogs prior to euthanasia.

作者信息

Ramsay E C, Wetzel R W

机构信息

Department of Comparative Medicine, College of Veterinary Medicine, University of Tennessee, Knoxville 37901-1071, USA.

出版信息

J Am Vet Med Assoc. 1998 Jul 15;213(2):240-2.

PMID:9676595
Abstract

OBJECTIVE

To compare regimens for oral administration of medication to induce sedation in dogs prior to euthanasia.

DESIGN

Prospective randomized clinical study.

ANIMALS

37 dogs.

PROCEDURE

Groups and medications were as follows: group 1, acepromazine (n = 8); group 2, tiletamine-zolazepam (8); group 3, tiletamine-zolazepam and acepromazine (8); group 4, tiletamine-zolazepam and butorphanol (6); and group 5, pentobarbital sodium (7). Capsules or tablets were placed in each dog's food. Sedation was scored at 3-minute intervals after consumption of medication for at least 60 minutes. Dogs with signs of persistent or progressive sedation were observed for 90 minutes.

RESULTS

Only 2 dogs in group 1 became slightly ataxic. All group-2 dogs were slightly ataxic, and 4 of 8 became laterally recumbent (mean time to lateral recumbency, 62 minutes). Seven of 8 group-3 dogs became sternally recumbent, and 6 of these dogs became laterally recumbent (mean, 48.6 minutes). Four of 6 group-4 dogs were slightly or moderately ataxic, and 1 of these dogs became laterally recumbent (mean, 48 minutes). One dog in group 5 was not affected by the medication, but all other group-5 dogs became laterally recumbent (mean, 59 minutes).

CLINICAL IMPLICATIONS

Of the medications evaluated, tiletamine-zolazepam and acepromazine at dosages of approximately 20 mg/kg (9.1 mg/lb) and 2 mg/kg (0.91 mg/lb), respectively, or pentobarbital sodium alone (63.2 +/- 5.1 mg/kg [28.7 +/- 2.3 mg/lb]) most consistently induced profound sedation and lateral recumbency after oral administration to dogs.

摘要

目的

比较安乐死之前给犬口服诱导镇静的药物方案。

设计

前瞻性随机临床研究。

动物

37只犬。

步骤

分组及用药如下:第1组,乙酰丙嗪(n = 8);第2组,替来他明-唑拉西泮(8只);第3组,替来他明-唑拉西泮与乙酰丙嗪(8只);第4组,替来他明-唑拉西泮与布托啡诺(6只);第5组,戊巴比妥钠(7只)。将胶囊或片剂放入每只犬的食物中。用药后每隔3分钟对镇静情况进行评分,至少持续60分钟。对出现持续或进展性镇静迹象的犬观察90分钟。

结果

第1组仅2只犬出现轻度共济失调。第2组所有犬均出现轻度共济失调,8只中有4只侧卧(侧卧平均时间为62分钟)。第3组8只中有7只俯卧,其中6只侧卧(平均48.6分钟)。第4组6只中有4只出现轻度或中度共济失调,其中1只侧卧(平均48分钟)。第5组1只犬未受药物影响,但其他所有犬均侧卧(平均59分钟)。

临床意义

在所评估的药物中,替来他明-唑拉西泮和乙酰丙嗪剂量分别约为20 mg/kg(9.1 mg/lb)和2 mg/kg(0.91 mg/lb),或单独使用戊巴比妥钠(63.2±5.1 mg/kg [28.7±2.3 mg/lb])给犬口服后,最常能持续诱导深度镇静和侧卧。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验